Giuliano Tosello

Prof. Dr. Giuliano Tosello

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2018 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
GTGiuliano Tosello
Giuliano Tosello
MTMaria Regina Torloni
Maria Regina Torloni
BMBruna S Mota
Bruna S Mota
TNTeresa Neeman
Teresa Neeman
RRRachel Riera
Rachel Riera

1 October 2018 in Experimental Gerontology
Verified
Journal Article
Closed access
TPThais R.S. de Paulo
Thais R.S. de Paulo
KWKerri M. Winters-Stone
Kerri M. Winters-Stone
JVJuliana Viezel
Juliana Viezel
FRFabricio E. Rossi
Fabricio E. Rossi
RSRegina R. Simões
Regina R. Simões
IFIsmael F. Freitas
Ismael F. Freitas

20 November 2025 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
GTGiuliano Tosello
Giuliano Tosello
RRRachel Riera
Rachel Riera
MTMaria Regina Torloni
Maria Regina Torloni
TNTeresa Neeman
Teresa Neeman
MCMarcelo Rs Cruz
Marcelo Rs Cruz
BMBruna S Mota
Bruna S Mota

3 September 2014 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
GTGiuliano Tosello
Giuliano Tosello
MTMaria R Torloni
Maria R Torloni
BSBruna Salani
Bruna Salani
TNTeresa Neeman
Teresa Neeman
RRRachel Riera
Rachel Riera

7 October 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
AAAdriano Anzai
Adriano Anzai
AUArmelin Utino
Armelin Utino
GTGiuliano Tosello
Giuliano Tosello
HKHaroldo Katayama
Haroldo Katayama
ISIghor Alexander Zamuner Spir
Ighor Alexander Zamuner Spir
WBWanderley Bernardo
Wanderley Bernardo

1 January 2021 in Mastology
Verified
Journal Article
Closed access
André MattarAndré Mattar
André Mattar
AYAdriana Akemi Yoshimura
Adriana Akemi Yoshimura
CFCarlos Elias Fristachi
Carlos Elias Fristachi
EPEduardo Carvalho Pessoa
Eduardo Carvalho Pessoa
FAFelipe Eduardo Martins Andrade
Felipe Eduardo Martins Andrade
ABAlfredo Carlos Simões Dornellas de Barros
Alfredo Carlos Simões Dornellas de Barros
Introduction: Breast cancer (BC) centers are increasingly attending “ultra-young” women (UYW) patients (≤ 30 years), who usually present aggressive tumors and face specific problems. Objectives: We aimed to examine a multicentric casuistic view, addressing clinicopathological and molecular characteristics of BC, as well as therapeutic measures and oncological outcomes. Methods: A retrospective multicentric observational study of UYW with infiltrating BC was carried out. The patients were treated between the period from January 1991 to December 2019. Clinical, epidemiological, morphological, molecular, therapeutic and outcomes data were collected from the charts. Results: A total of 293 patients were followed for a average period of 34.5 months. Nulliparity was referred by 204 women (75.5%), of whom 81 (37.1%) were overweight or obese. Positive family history in first-degree relatives was verified in 25 patients (10.1%). Only 30 patients underwent genetic tests, which revealed inherited pathogenic mutations in 12 of them (37.5%). Thirty-two (32) cases were classified as T1 at diagnosis (10.9%), while “De novo” stage IV was found in 29 patients (9.8%). Mastectomy was performed in 175 women (70.2%), quadrantectomy in 46 women (18.4%), and mammary adenectomies in 28 women (11.2%), of which 149 cases were reported after neoadjuvant chemotherapy (56.0%). A total of 111 patients had at least one positive lymph node (47.4%). The rate of patients with estrogen receptor-negative was 32.7% and the rate of patients with Human Epidermal Growth Factor Receptor 2-positive (HER2-positive) was 25%. The frequency of Luminal A neoplasias was 16.6%, Luminal B/HER2- was 35.9%, Luminal B/HER2+ was 15.1%, HER2 overexpressed was 9.3%, and Basal was 22.9%. Taking into account the outcomes, 173 patients were alive without disease (65.7%); 23 patients were alive with any form of recurrence (8.7%); and 67 patients (25.4%) evolved to BC deaths. Conclusions: It was concluded that UYW with BC are commonly diagnosed at advanced stages, present adverse morphological and molecular parameters, and have unfavorable prognosis.